MEDSTAR MONTGOMERY MEDICAL CENTER — History
CCN 210018 | 3-year financial timeline | COVID resilience: 27/100
🛡️ Public data only — no PHI permitted on this instance.
$174M
Latest Revenue (FY2022)
-0.8%
Revenue CAGR (3yr)
-14.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $177M | $190M | $174M | -8.5% | -0.8% |
| Operating Expenses | $184M | $206M | $198M | -3.6% | +3.7% |
| Operating Margin | -4.3% | -8.3% | -14.1% | -69.0% | +0.0% |
| Net Income | $-8M | $-16M | $-24M | -54.7% | +0.0% |
| Licensed Beds | 104 | 104 | 96 | -7.7% | -3.9% |
| Total Patient Days | 26,050 | 26,602 | 30,113 | +13.2% | +7.5% |
| Medicare Day % | 50% | 50% | 52% | +3.8% | +2.4% |
| Medicaid Day % | 5% | 11% | 11% | -0.4% | +39.7% |
COVID Impact & Recovery
Resilience Score: 27/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -1.7% ($177M → $174M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▼ Declining
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-0.8%
This Hospital
+7.6%
State Avg
Latest Margin
-14.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $172M | -19.0% |
| FY2024 (proj) | $171M | -23.9% |
| FY2025 (proj) | $169M | -28.8% |